Oncocyte™ is a precision diagnostics company with a mission to improve patient outcomes by providing personalized insights that inform critical decisions throughout the patient care journey. For more information, visit www.oncocyte.com.
Location: United States, California, Irvine
Employees: 51-200
Total raised: $5M
Founded date: 2009
Investors 1
| Date | Name | Website |
| - | Technology... | pivotcente... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 30.01.2020 | - | $5M | - |
Mentions in press and media 4
| Date | Title | Description |
| 07.01.2026 | Beyond Meat taps new chief accounting officer amid financial overhaul | Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Plant-based meat alternative provider Beyond Meat appointed Tony Kalajian to the role of chief accounting officer and principal a... |
| 12.04.2024 | Bio-Rad announces collaboration agreement with Oncocyte to commercialize transplant monitoring with Droplet Digital PCR | Collaboration Aims to Provide Researchers Cutting-Edge Tools to Enable Transformational Monitoring of Key Biomarkers in Solid Tissue Transplants HERCULES, Calif.— April 12, 2024 — Bio-Rad Laboratories, Inc., a global leader in life science ... |
| 15.05.2015 | Stem cell genes are helping inform this startup’s approach to cancer diagnostics | OncoCyte actually draws its diagnostic capability from the kind of stem cell research going on at BioTime – because the company itself pivoted away from embryonic stem cell-based cancer therapeutics and into the diagnostics space. Several g... |
| - | Stem cell genes are helping inform this startup’s approach to cancer diagnostics | A deep understanding of stem cell biology is helping Bay Area startup OncoCyte build out a new suite of cancer diagnostics. The company just raised $3.3 million from two private investors; it’s majority owned, however, by the publicly trade... |